SCHEMBL13387565

SCHEMBL13387565

COCCOCCn1c2ccccc2c2cc(C=O)ccc21

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 7/20 0.85
▸ APP P05067 3/20 0.60
▸ MEN1 O00255 4/20 0.51
▸ KMT2A Q03164 4/20 0.51
▸ SRC P12931 2/20 0.46
▸ KDM4E B2RXH2 4/20 0.45
▸ ALDH1A1 P00352 4/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ PKM P14618 2/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ NFKB2 Q00653 1/20 0.45
▸ RELA Q04206 1/20 0.45
▸ CNR2 P34972 1/20 0.43
▸ HPGD P15428 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ POLB P06746 2/20 0.42
▸ HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30295042 1.00 PTGER4 (0.85) PTGER4APPMEN1KMT2ASRC
SCHEMBL12479908 1.00 PTGER4 (0.85) PTGER4APPMEN1KMT2ASRC
SCHEMBL13635119 0.93 PTGER4 (0.73) PTGER4APPMEN1KMT2AKDM4E
SCHEMBL15774498 0.92 PTGER4 (1.00) PTGER4APPMEN1KMT2ASRC
SCHEMBL15901783 0.86 PTGER4 (0.64) PTGER4APPMEN1KMT2AKDM4E
SCHEMBL15774938 0.86 PTGER4 (0.88) PTGER4APPSRCKDM4EPKM
SCHEMBL28288523 0.85 PTGER4 (0.63) PTGER4APPCNR2
SCHEMBL26262783 0.85 PTGER4 (0.86) PTGER4APPSRCALDH1A1CNR2
SCHEMBL2143204 0.84 MEN1 (0.62) PTGER4APPMEN1KMT2AKDM4E
SCHEMBL13387568 0.84 MEN1 (0.70) PTGER4APPMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9795694-B2 Imaging beta-amyloid peptides aggregation HONG KONG BAPTIST UNIVERSITY (HK) 2017-10-24 — — US disclosed
US-9795694-B2 Imaging beta-amyloid peptides aggregation HONG KONG BAPTIST UNIVERSITY (HK) 2017-10-24 — — US disclosed
CN-102743769-B Imaging of beta-amyloid peptide and inhibition of beta-amyloid peptide aggregation 香港浸会大学 2016-11-02 — — CN disclosed
US-20160243264-A1 Imaging Beta-Amyloid Peptides Aggregation HONG KONG BAPTIST UNIVERSITY (HK) 2016-08-25 — — US disclosed
US-20160243264-A1 Imaging Beta-Amyloid Peptides Aggregation HONG KONG BAPTIST UNIVERSITY (HK) 2016-08-25 — — US disclosed
US-9403794-B2 Imaging beta-amyloid peptides and inhibition of beta-amyloid peptide aggregation HONG KONG BAPTIST UNIVERSITY (HK) 2016-08-02 — — US disclosed
US-9255933-B2 Imaging beta-amyloid peptides and inhibition of beta-amyloid peptide aggregation HONG KONG BAPTIST UNIVERSITY (HK) 2016-02-09 — — US disclosed
US-9156814-B2 Imaging beta-amyloid peptides and inhibition of beta-amyloid peptide aggregation HONG KONG BAPTIST UNIVERSITY (HK) 2015-10-13 — — US disclosed
US-20140213614-A1 Imaging Beta-Amyloid Peptides and Inhibition of Beta-Amyloid Peptide Aggregation HONG KONG BAPTIST UNIVERSITY (HK) 2014-07-31 — — US disclosed
US-20140212360-A1 Imaging Beta-Amyloid Peptides and Inhibition of Beta-Amyloid Peptide Aggregation HONG KONG BAPTIST UNIVERSITY (HK) 2014-07-31 — — US disclosed
US-20120269738-A1 Imaging Beta-Amyloid Peptides and Inhibition of Beta-Amyloid Peptide Aggregation HONG KONG BAPTIST UNIVERSITY (HK) 2012-10-25 — — US disclosed
CN-102743769-A Imaging of Beta-amyloid peptide and inhibition of Beta-amyloid Peptide aggregation UNIV HONG KONG BAPTIST 2012-10-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120269738-A1 Imaging Beta-Amyloid Peptides and Inhibition of Beta-Amyloid Peptide Aggregation APP, IAPP, BACE1 PTGER4 4506/4885APP 1/4885MEN1 1083/4885
US-20140213614-A1 Imaging Beta-Amyloid Peptides and Inhibition of Beta-Amyloid Peptide Aggregation APP, IAPP, BACE1 PTGER4 4252/4885APP 1/4885MEN1 1083/4885
US-20160243264-A1 Imaging Beta-Amyloid Peptides Aggregation APP, IAPP, APBA1 PTGER4 4526/4885APP 1/4885MEN1 304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback